Skip to main content
Defiance International

Published study records

Study records for Selank

Study records describe published research and its limitations. They do not establish efficacy, safety, or suitability for any use.

Study record counts

104 study records.

0 evidence-verified · 101 citation-verified · 3 citation-only

Verified records by research setting

  • Human research: 13
  • In vitro: 14
  • In vivo/preclinical: 74
  • Review/meta-analysis: 0
  • Other: 0
Filter study recordsReset filters

Current study records

Study type: In vivo/preclinical · Status: Citation identity verified

Combined Action of Benzodiazepine Tranquilizers and Peptide Anxiolytic Selank in BALB/с Mice

Neurochemical Journal · 2025

Study scale: Not reported in the declared source.

Citation only: Open source record

Product or molecular entity relationships

  • Selank: Catalog source association. Legacy citation custody associates this source with the catalog record; no product-relevance conclusion is implied.

No public summary

No plain-language summary is published in this record. Summary availability is separate from its review status. Consult the cited publication when a public link is available.

Limitations and uncertainty

Not reported in the declared source.

Citation identity verified. Verification is limited to the declared source and review scope. It does not mean independent replication or establish efficacy, safety, or suitability.

Study type: In vivo/preclinical · Status: Citation identity verified

Combined Action of Benzodiazepine Tranquiizers and the Peptide Anxiolytic Selank on BALB/с Mice

Нейрохимия / Neurochemical Journal · 2025

Study scale: Not reported in the declared source.

Citation only: Open source record

Product or molecular entity relationships

  • Selank: Catalog source association. Legacy citation custody associates this source with the catalog record; no product-relevance conclusion is implied.

No public summary

No plain-language summary is published in this record. Summary availability is separate from its review status. Consult the cited publication when a public link is available.

Limitations and uncertainty

Not reported in the declared source.

Citation identity verified. Verification is limited to the declared source and review scope. It does not mean independent replication or establish efficacy, safety, or suitability.

Study type: In vivo/preclinical · Status: Citation identity verified

Role of Semax and Selank neuropeptides in modulating cell-mediated immunity in the setting of skin burn injury

RUDN Journal of Medicine · 2024

Study scale: Not reported in the declared source.

Citation only: Open source record

Product or molecular entity relationships

  • Selank: Catalog source association. Legacy citation custody associates this source with the catalog record; no product-relevance conclusion is implied.

No public summary

No plain-language summary is published in this record. Summary availability is separate from its review status. Consult the cited publication when a public link is available.

Limitations and uncertainty

Not reported in the declared source.

Citation identity verified. Verification is limited to the declared source and review scope. It does not mean independent replication or establish efficacy, safety, or suitability.

Study type: Human research · Status: Citation identity verified

POST-COVID SYNDROME, POSSIBILITIES FOR THERAPY OF ASTHENIC DISORDERS WITH SELANK

Vrach · 2024

Study scale: Not reported in the declared source.

Citation only: Open source record

Product or molecular entity relationships

  • Selank: Catalog source association. Legacy citation custody associates this source with the catalog record; no product-relevance conclusion is implied.

No public summary

No plain-language summary is published in this record. Summary availability is separate from its review status. Consult the cited publication when a public link is available.

Limitations and uncertainty

Not reported in the declared source.

Citation identity verified. Verification is limited to the declared source and review scope. It does not mean independent replication or establish efficacy, safety, or suitability.

Study type: In vivo/preclinical · Status: Citation identity verified

Selank Peptide Causes Changes in Gene Expression in the Hippocampus of Rats in the Early Hours after Acute Restraint Stress

Nanobiotechnology Reports · 2024

Study scale: Not reported in the declared source.

Citation only: Open source record

Product or molecular entity relationships

  • Selank: Catalog source association. Legacy citation custody associates this source with the catalog record; no product-relevance conclusion is implied.

No public summary

No plain-language summary is published in this record. Summary availability is separate from its review status. Consult the cited publication when a public link is available.

Limitations and uncertainty

Not reported in the declared source.

Citation identity verified. Verification is limited to the declared source and review scope. It does not mean independent replication or establish efficacy, safety, or suitability.

Study type: In vivo/preclinical · Status: Citation identity verified

State of nervous system functions of Wistar rats when using peptide taftsin-PGP (selank) in restraint stress

Человек и его здоровье · 2023

Study scale: Not reported in the declared source.

Citation only: Open source record

Product or molecular entity relationships

  • Selank: Catalog source association. Legacy citation custody associates this source with the catalog record; no product-relevance conclusion is implied.

No public summary

No plain-language summary is published in this record. Summary availability is separate from its review status. Consult the cited publication when a public link is available.

Limitations and uncertainty

Not reported in the declared source.

Citation identity verified. Verification is limited to the declared source and review scope. It does not mean independent replication or establish efficacy, safety, or suitability.

Study type: In vivo/preclinical · Status: Citation identity verified

Transcriptomic reaction of the rat hippocampus and spleen to singular and course injection of selank peptide

Journal of Clinical Physiology and Pathology · 2023

Study scale: Not reported in the declared source.

Citation only: Open source record

Product or molecular entity relationships

  • Selank: Catalog source association. Legacy citation custody associates this source with the catalog record; no product-relevance conclusion is implied.

No public summary

No plain-language summary is published in this record. Summary availability is separate from its review status. Consult the cited publication when a public link is available.

Limitations and uncertainty

Not reported in the declared source.

Citation identity verified. Verification is limited to the declared source and review scope. It does not mean independent replication or establish efficacy, safety, or suitability.

Study type: In vivo/preclinical · Status: Citation identity verified

Common and Specific Effects of Selank, Noopept, and Semax to Glycine Site of the NMDA Receptor in BALB/c and C57Bl/6 Mice Brain

Нейрохимия · 2023

Study scale: Not reported in the declared source.

Citation only: Open source record

Product or molecular entity relationships

  • Selank: Catalog source association. Legacy citation custody associates this source with the catalog record; no product-relevance conclusion is implied.

No public summary

No plain-language summary is published in this record. Summary availability is separate from its review status. Consult the cited publication when a public link is available.

Limitations and uncertainty

Not reported in the declared source.

Citation identity verified. Verification is limited to the declared source and review scope. It does not mean independent replication or establish efficacy, safety, or suitability.

Study type: In vivo/preclinical · Status: Citation identity verified

Common and Specific Effects of Selank, Noopept, and Semax on the Glycine Site of the NMDA Receptor in BALB/c and C57Bl/6 Mice Brains

Neurochemical Journal · 2023

Study scale: Not reported in the declared source.

Citation only: Open source record

Product or molecular entity relationships

  • Selank: Catalog source association. Legacy citation custody associates this source with the catalog record; no product-relevance conclusion is implied.

No public summary

No plain-language summary is published in this record. Summary availability is separate from its review status. Consult the cited publication when a public link is available.

Limitations and uncertainty

Not reported in the declared source.

Citation identity verified. Verification is limited to the declared source and review scope. It does not mean independent replication or establish efficacy, safety, or suitability.

Study type: In vivo/preclinical · Status: Citation identity verified

Changes in Expression of Chemokines, Cytokines and their Receptors under the Action of Selank and its Fragments

Journal of Clinical Physiology and Pathology · 2023

Study scale: Not reported in the declared source.

Citation only: Open source record

Product or molecular entity relationships

  • Selank: Catalog source association. Legacy citation custody associates this source with the catalog record; no product-relevance conclusion is implied.

No public summary

No plain-language summary is published in this record. Summary availability is separate from its review status. Consult the cited publication when a public link is available.

Limitations and uncertainty

Not reported in the declared source.

Citation identity verified. Verification is limited to the declared source and review scope. It does not mean independent replication or establish efficacy, safety, or suitability.

Study type: In vivo/preclinical · Status: Citation identity verified

The peptide analog of tuftsin selank attenuates the aversive signs of morphine withdrawal in rats

Bulletin of Experimental Biology and Medicine · 2022

Study scale: Not reported in the declared source.

Citation only: Open source record

Product or molecular entity relationships

  • Selank: Catalog source association. Legacy citation custody associates this source with the catalog record; no product-relevance conclusion is implied.

No public summary

No plain-language summary is published in this record. Summary availability is separate from its review status. Consult the cited publication when a public link is available.

Limitations and uncertainty

Not reported in the declared source.

Citation identity verified. Verification is limited to the declared source and review scope. It does not mean independent replication or establish efficacy, safety, or suitability.

Study type: In vivo/preclinical · Status: Citation identity verified

Selank effects on morphine-induced analgesia in vivo experiments

Pharmacokinetics and Pharmacodynamics · 2022

Study scale: Not reported in the declared source.

Citation only: Open source record

Product or molecular entity relationships

  • Selank: Catalog source association. Legacy citation custody associates this source with the catalog record; no product-relevance conclusion is implied.

No public summary

No plain-language summary is published in this record. Summary availability is separate from its review status. Consult the cited publication when a public link is available.

Limitations and uncertainty

Not reported in the declared source.

Citation identity verified. Verification is limited to the declared source and review scope. It does not mean independent replication or establish efficacy, safety, or suitability.